Neuland Vilanterol Trifenatate Neuland Vilanterol Trifenatate

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Vilanterol Trifenatate manufacturers, exporters & distributors on PharmaCompass

    Client Email Product

    Vilanterol

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    26
    US DMFs Filed

    US DMFs Filed

    7
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    4
    Other Suppliers

    Other Suppliers

    23
    API REF. PRICE (USD / KG)
    315,301

    API Market Place

    2
    INTERMEDIATES
    10
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    6
    Europe

    Europe

    12
    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    3
    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    35
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    110

    USFDA Exclusivities

    4
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    41
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    10
    SERVICES

    0

    Vilanterol
    Also known as: 503070-58-4, Vilanterol trifenate, Vilanterol (trifenatate), Gw642444m, Unii-40aho2c6dg, Chebi:75040
    Molecular Formula
    C44H49Cl2NO7
    Molecular Weight
    774.8  g/mol
    InChI Key
    KLOLZALDXGTNQE-JIDHJSLPSA-N
    FDA UNII
    40AHO2C6DG
    1 2D Structure

    Vilanterol

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[(1R)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;2,2,2-triphenylacetic acid
    2.1.2 InChI
    InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m0./s1
    2.1.3 InChI Key
    KLOLZALDXGTNQE-JIDHJSLPSA-N
    2.1.4 Canonical SMILES
    C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl
    2.1.5 Isomeric SMILES
    C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl
    2.2 Other Identifiers
    2.2.1 UNII
    40AHO2C6DG
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 503070-58-4

    2. Vilanterol Trifenate

    3. Vilanterol (trifenatate)

    4. Gw642444m

    5. Unii-40aho2c6dg

    6. Chebi:75040

    7. Gw 642444m

    8. Gw-642444m

    9. Vilanterol (as Trifenatate)

    10. 40aho2c6dg

    11. Vilanterol Trifenatate [usan]

    12. 4-[(1r)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;2,2,2-triphenylacetic Acid

    13. Benzeneacetic Acid, Alpha,alpha-diphenyl-, Compd. With (alpha1r)-alpha1-[[[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-4-hydroxy-1,3-benzenedimethanol (1

    14. Triphenylacetic Acid-4-((1r)-2-((6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol (1:1)

    15. Vilanterol Triphenylacetate

    16. Gw642444 (trifenatate)

    17. Schembl164639

    18. Chembl1084172

    19. Dtxsid80659232

    20. Hms3885o21

    21. Vilanterol Trifenatate [mi]

    22. Amy30059

    23. Bcp18862

    24. Ex-a4159

    25. Vilanterol Trifenatate (jan/usan)

    26. Vilanterol Trifenatate [jan]

    27. Hy-14300a

    28. S3727

    29. Ccg-270458

    30. Cs-1679

    31. Vilanterol Trifenatate [who-dd]

    32. Vilanterol Trifenatate [orange Book]

    33. D09697

    34. F11535

    35. A899729

    36. Breo Ellipta Component Vilanterol Trifenatate

    37. Anoro Ellipta Component Vilanterol Trifenatate

    38. Q27145087

    39. Trelegy Ellipta Component Vilanterol Trifenatate

    40. Vilanterol Trifenatate Component Anoro Ellipta

    41. Gw 642444x;gw-642444x;gw642444x

    42. Vilanterol Trifenatate Component Of Breo Ellipta

    43. Vilanterol Trifenatate Component Of Trelegy Ellipta

    44. 4-((1r)-2-((6-(2-((2,6-dichlorophenyl)methoxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol Triphenylacetate

    45. 4-[(1r)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol,2,2,2-triphenylacetic Acid

    46. 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol Triphenylacetate

    47. 6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}-n-{(2r)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}hexan-1-aminium Triphenylacetate

    48. Benzeneacetic Acid, Alpha,alpha-diphenyl-, Compd. With (alpha1r)-alpha1-(((6-(2-((2,6-dichlorophenyl)methoxy)ethoxy)hexyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol (1:1)

    49. Triphenylacetic Acid--4-{(1r)-2-[(6-{2-[(2,6-dichlorophenyl)methoxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1/1)

    50. Triphenylacetic Acid-4-((1r)-2-((6-(2-(2,6-dicholorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol (1:1)

    2.4 Create Date
    2009-12-15
    3 Chemical and Physical Properties
    Molecular Weight 774.8 g/mol
    Molecular Formula C44H49Cl2NO7
    Hydrogen Bond Donor Count5
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count20
    Exact Mass773.2886083 g/mol
    Monoisotopic Mass773.2886083 g/mol
    Topological Polar Surface Area129 Ų
    Heavy Atom Count54
    Formal Charge0
    Complexity778
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    left grey arrow
    right gray arrow
    • POWDER;INHALATION - EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH
    • POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH
    • POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH
    • POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Inke Vilanterol Trifenatate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search